drugset / Trial / NCT05856487
To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety NVP-2203 in patients
Timeline
- Start
- 2023-06-30
- Primary completion
- 2024-05-31
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NVP-2203 | Unknown | — | Oral |
| Comparator | NVP-2203-R1 | Unknown | — | Oral |
| Comparator | NVP-2203-R2 | Unknown | — | Oral |
| Comparator | NVP-2203-R3 | Unknown | — | Oral |